Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Wegovy and Ozempic top list of 15 drugs up for next price negotiations
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year, with resulting bargained prices going into effect in 2027.
These medications were sitagliptin, liraglutide, glimepiride, or insulin glargine U-100. Sitagliptin, liraglutide, and ...
Type 2 diabetes is a condition where the body doesn’t make enough of the hormone insulin or use it effectively. Here, MDs ...
A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...
Type 2 diabetes is a chronic condition that affects the body’s ability to regulate blood sugar levels. For many patients, ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
Imagine reversing a life-altering condition without the use of drugs. One British GP is doing exactly that, and his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback